EANO

EANO
Name	EANO
Formation	1994
Type	Non-profit scientific society
Headquarters	Europe
Membership	Clinicians, researchers, allied professionals
Leader title	President

EANO

The European Association of Neuro-Oncology (EANO) is a professional organization focused on the science, clinical care, and policy of brain and spinal cord tumors across Europe. It brings together clinicians, researchers, allied health professionals, patient representatives, and industry partners from diverse institutions such as Oxford University Hospitals NHS Foundation Trust, Institut Curie, Charité – Universitätsmedizin Berlin, University of Cambridge, and Aarhus University Hospital to promote multidisciplinary collaboration. EANO fosters links with international bodies including American Society of Clinical Oncology, International Brain Tumour Alliance, World Health Organization, European Commission, and European Society for Medical Oncology to harmonize standards, research priorities, and patient care pathways.

History

EANO was established in 1994 amid growing concern about inconsistent care and fragmented research for central nervous system neoplasms across United Kingdom, France, Germany, Italy, and other European states. Early initiatives convened experts from University of Turin, Karolinska Institutet, Leiden University Medical Center, King's College London, and University of Barcelona to draft consensus statements and coordinate multicenter trials. Over successive decades EANO integrated professionals from institutions such as Mayo Clinic collaborators, Dana–Farber Cancer Institute partners, and researchers from Max Planck Society-affiliated centers, expanding its remit to include guideline development, education, and advocacy. Landmark events in its history include collaborations on classification updates with World Health Organization tumor committees and participation in pan-European research consortia tied to frameworks such as Horizon 2020 and European Research Council grants.

Structure and Membership

EANO’s governance typically comprises an elected Board, a Scientific Committee, working groups, and advisory panels drawing members from university hospitals, national cancer institutes, and research centers like Sveriges Kommuner och Landsting-affiliated clinics, Institut Gustave Roussy, University of Amsterdam, and University of Vienna. Membership categories cover full members, associate members, trainee members, and corporate partners from biomedical companies and foundations such as Leukemia & Lymphoma Society collaborators and philanthropic bodies like Wellcome Trust. National neuro-oncology societies from Poland, Spain, Netherlands, Greece, and Sweden engage as affiliated organizations. Elections for leadership positions involve representatives from major centers including University College London Hospitals NHS Foundation Trust and Erasmus MC. Committees coordinate with ethics boards and data governance units at institutions such as European Bioinformatics Institute.

Activities and Programs

EANO runs thematic working groups addressing gliomas, meningiomas, medulloblastomas, and spinal tumors, partnering with translational hubs at Institut Pasteur, Imperial College London, University of Zurich, University of Milan, and KU Leuven. Programs include registries, tumor board networks, quality-of-care audits, and patient-reported outcome initiatives tied to clinics like St. James's Hospital, Dublin and Hôpital Pitié-Salpêtrière. Collaborative projects leverage platforms from European Molecular Biology Laboratory and biobanks linked to BBMRI-ERIC to facilitate biomarker research. Capacity building and fellowship programs connect trainees to centers such as Addenbrooke's Hospital, Hospital Clínic de Barcelona, and Helsinki University Hospital.

Research and Clinical Guidelines

EANO develops clinical practice guidelines and consensus recommendations on diagnosis, molecular classification, surgical management, radiotherapy, and systemic therapies, aligning with classification efforts by World Health Organization tumor panels and molecular taxonomy work from The Cancer Genome Atlas consortium. Guidelines address use of imaging modalities from National Institutes of Health-linked protocols and advanced techniques from centers like Mayo Clinic and Charité – Universitätsmedizin Berlin. EANO-sponsored trials and observational studies have intersected with cooperative groups such as European Organisation for Research and Treatment of Cancer and national networks like German Cancer Research Center. The association issues position papers on biomarker-driven therapy, tumor sequencing, and integrated diagnostics in collaboration with pathology societies at institutions including Royal College of Pathologists.

Education and Training

EANO organizes educational courses, hands-on workshops, and fellowship exchanges involving neurosurgery, neuro-oncology, neuropathology, neuroradiology, and radiation oncology departments from University of Oxford, Sapienza University of Rome, Technical University of Munich, Trinity College Dublin, and University of Helsinki. Training programs emphasize multidisciplinary tumor boards modeled on practices at Johns Hopkins Hospital and incorporate sessions on clinical trial design, biostatistics, and regulatory frameworks referenced to European Medicines Agency standards. A mentorship scheme links junior investigators to senior faculty from centers such as Memorial Sloan Kettering Cancer Center and St. Jude Children's Research Hospital.

Advocacy and Policy

EANO engages in advocacy to improve access to diagnostics, specialized care, and novel therapies across member states, interfacing with policy actors like European Parliament committees, national ministries of health in Belgium and Portugal, and patient advocacy organizations including Brain Tumour Charity. Policy efforts address reimbursement, rare tumor pathways, cross-border care under directives from European Commission, and research funding priorities through mechanisms such as Horizon Europe.

Conferences and Publications

EANO hosts annual congresses and focused symposia attracting participants from leading centers including University of Pennsylvania, Harvard Medical School, University of Toronto, Seoul National University Hospital, and National Cancer Center Japan. Its publications program features clinical practice guidelines, consensus statements, and educational materials disseminated in peer-reviewed journals and collaborative supplements with publishers and societies like Nature Publishing Group and Oxford University Press. Proceedings and position papers inform translational research agendas and clinical practice across Europe and beyond.

Category:Medical associations